BIM — Biomerieux SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Biomerieux SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,118	3,376	3,589	3,675	3,980
Cost of Revenue
Gross Profit	1,754	2,001	2,009	2,057	2,215
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,566	2,591	3,002	3,239	3,391
Operating Profit	552	785	587	436	589
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	524	775	581	437	579
Provision for Income Taxes
Net Income After Taxes	403	599	441	323	425
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	404	601	452	358	432
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	404	601	452	358	432
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.41	5.05	3.82	3.79	3.78
Dividends per Share